VELETRIの世界市場レポート 2025年

VELETRI市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.7％で19億5,000万米ドルに成長します。予測期間中の成長は、静脈疾患の有病率の上昇、認知度の向上と早期診断、慢性疾患に対する支出の増加、ヘルスケアインフラの改善、患者人口の増加に起因すると考えられます。この期間の主要動向としては、技術の進歩、製薬企業と研究機関の提携、臨床研究の強力なパイプライン、研究開発活動の増加、バイオシミラーやジェネリック医薬品の出現などが挙げられます。

肺動脈性肺高血圧症（PAH）の有病率の増加は、今後のVELETRI市場の拡大を牽引すると予想されます。PAHは、肺動脈の高血圧を特徴とするまれな進行性疾患で、放置すると心不全を引き起こす可能性があります。PAHの有病率が増加している背景には、診断技術の向上、高齢化、疾患に対する意識の高まりなどの要因があります。VELETRIは、血管拡大により運動能力を向上させ、疾患の進行を遅らせることでPAHを治療するために使用されます。例えば、2022年10月、米国の非営利医療会である米国心臓病学会（American College of Cardiology Foundation）は、PAHは100万人あたり約15～30人が罹患していると報告しました。PAHの有病率の上昇に伴い、VELETRIの需要は拡大すると予想されます。

静脈疾患の罹患率の増加も、VELETRI市場を前進させると予想されます。静脈疾患は、静脈が血流障害を起こすことで発生し、腫れや痛みなどの症状や、静脈瘤や深部静脈血栓症などの潜在的な合併症を引き起こします。静脈疾患の有病率の増加は、高齢化、座りがちなライフスタイル、肥満、診断能力の向上などの要因に影響されています。VELETRIは、肺血管系に影響を及ぼす静脈疾患患者の運動能力を改善し、症状を緩和するために使用されます。例えば、2025年1月、米国疾病予防管理センター（CDC）は、血栓の原因となる静脈血栓塞栓症（VTE）が米国で年間90万人に影響し、毎年6万～10万人がVTEに関連して死亡していると推定されると報告しました。静脈疾患は増加の一途をたどっており、VELETRI市場も成長する可能性が高いです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場-マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のVELETRI PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のVELETRI市場：成長率分析
• 世界のVELETRI市場の実績：規模と成長、2019～2024年
• 世界のVELETRI市場の予測：規模と成長、2024～2029年、2034年
• 世界のVELETRI総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のVELETRI市場：製品タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 注射剤
• 吸入
• 世界のVELETRI市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 肺動脈高血圧
• その他
• 世界のVELETRI市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界のVELETRI市場、注射剤のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 静脈内（IV）注射
• 皮下注射
• 世界のVELETRI市場、吸入のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ネブライザー吸入
• 乾燥粉末吸入

第7章 地域別・国別分析

• 世界のVELETRI市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のVELETRI市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• VELETRI市場：競合情勢
• VELETRI市場：企業プロファイル
  • Johnson & Johnson
  • Bayer Pharma AG
  • Novartis AG
  • GlaxoSmithKline plc
  • Gilead Sciences Inc.

第31章 その他の大手企業と革新的企業

• Teva Pharmaceutical Industries Ltd.
• Boehringer Ingelheim International GmbH
• Sandoz International GmbH
• Sun Pharmaceutical Industries Ltd.
• Actelion Pharmaceuticals Ltd.
• Euroapi S.A.
• United Therapeutics Corporation
• Pfizer CentreOne
• Sai Life Sciences Limited
• Zhejiang Ausun Pharmaceutical Co. Ltd.
• Yonsung Fine Chemicals Co. Ltd.
• Cayman Pharma S.r.o.
• Meitheal Pharmaceuticals Inc.
• Smiths Medical
• Guangzhou Tosun Pharmaceutical Co. Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

• VELETRI市場、2029年：新たな機会を提供する国
• VELETRI市場、2029年：新たな機会を提供するセグメント
• VELETRI市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

VELETRI (epoprostenol) is a prostacyclin vasodilator used to treat pulmonary arterial hypertension (PAH). It works by relaxing blood vessels and improving blood flow, which helps lower blood pressure in the lungs. Unlike Flolan, VELETRI does not require refrigeration, making it more convenient for continuous infusion. It is administered intravenously to enhance exercise capacity and alleviate symptoms in PAH patients.

The primary types of VELETRI are injectable and inhalation. The injectable form is a prostacyclin (epoprostenol) therapy used to treat pulmonary arterial hypertension (PAH), improving both exercise capacity and symptoms. It has various applications, including PAH and other conditions, and is distributed through a range of channels, such as hospital pharmacies, retail pharmacies, and online pharmacies.

The VELETRI market research report is one of a series of new reports from The Business Research Company that provides VELETRI market statistics, including the VELETRI industry global market size, regional shares, competitors with the VELETRI market share, detailed VELETRI market segments, market trends, and opportunities, and any further data you may need to thrive in the VELETRI industry. This VELETRI market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The VELETRI market size has grown strongly in recent years. It will grow from $1.34 billion in 2024 to $1.45 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth during the historical period can be attributed to several factors, including the rising prevalence of pulmonary arterial hypertension (PAH), greater awareness of the condition, an expanding elderly population, global increases in lifestyle-related health issues, and higher healthcare expenditure.

The VELETRI market size is expected to see strong growth in the next few years. It will grow to $1.95 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth during the forecast period can be attributed to the rising prevalence of venous diseases, increased awareness and early diagnosis, higher spending on chronic diseases, improved healthcare infrastructure, and a growing patient population. Key trends in this period include technological advancements, collaborations between pharmaceutical companies and research institutions, a strong pipeline of clinical research, an increase in R&D activities, and the emergence of biosimilars and generics.

The growing prevalence of pulmonary arterial hypertension (PAH) is expected to drive the expansion of the VELETRI market in the future. PAH is a rare, progressive disease characterized by high blood pressure in the lung arteries, which can lead to heart failure if left untreated. The increasing prevalence of PAH is due to factors such as enhanced diagnostic techniques, an aging population, and heightened awareness of the condition. VELETRI is used to treat PAH by improving exercise capacity and slowing disease progression through vasodilation. For example, in October 2022, the American College of Cardiology Foundation, a US-based nonprofit medical society, reported that PAH affects approximately 15 to 30 people per million. As the prevalence of PAH rises, the demand for VELETRI is expected to grow.

The growing incidence of venous diseases is also expected to drive the VELETRI market forward. Venous diseases occur when veins experience impaired blood flow, resulting in symptoms such as swelling, pain, and potential complications such as varicose veins and deep vein thrombosis. The increasing prevalence of venous diseases is influenced by factors such as an aging population, sedentary lifestyles, obesity, and better diagnostic capabilities. VELETRI is used to improve exercise capacity and alleviate symptoms in patients with venous diseases affecting the pulmonary vasculature. For instance, in January 2025, the Centers for Disease Control and Prevention (CDC) reported that venous thromboembolism (VTE), which causes blood clots, impacts up to 900,000 people annually in the United States, with an estimated 60,000 to 100,000 deaths linked to VTE each year. As venous diseases continue to rise, the VELETRI market will likely grow.

Rising healthcare spending is also expected to fuel the demand for VELETRI. The increase in healthcare expenditure is driven by factors such as aging populations, advanced medical technologies, a rise in chronic diseases, and higher drug and treatment costs. The growth in healthcare spending ensures the affordability, accessibility, and continued research of VELETRI, making it available for PAH patients who require long-term intravenous therapy. For instance, in November 2024, Eurostat, a Luxembourg-based governmental organization, reported that healthcare expenditure in Europe rose from $1.69 trillion in 2021 to $1.75 trillion in 2022, marking a 3.6% increase. This growing healthcare investment is expected to further drive the expansion of the VELETRI market.

Major players in the VELETRI market are Johnson & Johnson, Bayer Pharma AG, Novartis AG, GlaxoSmithKline plc, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Actelion Pharmaceuticals Ltd., Euroapi S.A., United Therapeutics Corporation, Pfizer CentreOne, Sai Life Sciences Limited, Zhejiang Ausun Pharmaceutical Co. Ltd., Yonsung Fine Chemicals Co. Ltd., Cayman Pharma S.r.o., Meitheal Pharmaceuticals Inc., Smiths Medical, and Guangzhou Tosun Pharmaceutical Co. Ltd.

North America was the largest region in the VELETRI market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in VELETRI report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the VELETRI market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The VELETRI market consists of sales of injections, biosimilars, infusion systems, and related equipment. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

VELETRI Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on veletri market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veletri ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The veletri market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Injectable; Inhalation
• 2) By Application: Pulmonary Arterial Hypertension; Other Applications
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• Subsegments:
• 1) By Injectable: Intravenous (IV) Injection; Subcutaneous (SC) Injection
• 2) By Inhalation: Nebulized Inhalation; Dry Powder Inhalation
• Companies Mentioned: Johnson & Johnson; Bayer Pharma AG; Novartis AG; GlaxoSmithKline plc; Gilead Sciences Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. VELETRI Market Characteristics

3. VELETRI Market Trends And Strategies

4. VELETRI Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global VELETRI Growth Analysis And Strategic Analysis Framework

• 5.1. Global VELETRI PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global VELETRI Market Growth Rate Analysis
• 5.4. Global VELETRI Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global VELETRI Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global VELETRI Total Addressable Market (TAM)

6. VELETRI Market Segmentation

• 6.1. Global VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable
• Inhalation
• 6.2. Global VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pulmonary Arterial Hypertension
• Other Applications
• 6.3. Global VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.4. Global VELETRI Market, Sub-Segmentation Of Injectable, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intravenous (IV) Injection
• Subcutaneous (SC) Injection
• 6.5. Global VELETRI Market, Sub-Segmentation Of Inhalation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nebulized Inhalation
• Dry Powder Inhalation

7. VELETRI Market Regional And Country Analysis

• 7.1. Global VELETRI Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global VELETRI Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific VELETRI Market

• 8.1. Asia-Pacific VELETRI Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China VELETRI Market

• 9.1. China VELETRI Market Overview
• 9.2. China VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India VELETRI Market

• 10.1. India VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan VELETRI Market

• 11.1. Japan VELETRI Market Overview
• 11.2. Japan VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia VELETRI Market

• 12.1. Australia VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia VELETRI Market

• 13.1. Indonesia VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea VELETRI Market

• 14.1. South Korea VELETRI Market Overview
• 14.2. South Korea VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe VELETRI Market

• 15.1. Western Europe VELETRI Market Overview
• 15.2. Western Europe VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK VELETRI Market

• 16.1. UK VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany VELETRI Market

• 17.1. Germany VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France VELETRI Market

• 18.1. France VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy VELETRI Market

• 19.1. Italy VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain VELETRI Market

• 20.1. Spain VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe VELETRI Market

• 21.1. Eastern Europe VELETRI Market Overview
• 21.2. Eastern Europe VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia VELETRI Market

• 22.1. Russia VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America VELETRI Market

• 23.1. North America VELETRI Market Overview
• 23.2. North America VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA VELETRI Market

• 24.1. USA VELETRI Market Overview
• 24.2. USA VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada VELETRI Market

• 25.1. Canada VELETRI Market Overview
• 25.2. Canada VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America VELETRI Market

• 26.1. South America VELETRI Market Overview
• 26.2. South America VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil VELETRI Market

• 27.1. Brazil VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East VELETRI Market

• 28.1. Middle East VELETRI Market Overview
• 28.2. Middle East VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa VELETRI Market

• 29.1. Africa VELETRI Market Overview
• 29.2. Africa VELETRI Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa VELETRI Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa VELETRI Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. VELETRI Market Competitive Landscape And Company Profiles

• 30.1. VELETRI Market Competitive Landscape
• 30.2. VELETRI Market Company Profiles
  • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bayer Pharma AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis

31. VELETRI Market Other Major And Innovative Companies

• 31.1. Teva Pharmaceutical Industries Ltd.
• 31.2. Boehringer Ingelheim International GmbH
• 31.3. Sandoz International GmbH
• 31.4. Sun Pharmaceutical Industries Ltd.
• 31.5. Actelion Pharmaceuticals Ltd.
• 31.6. Euroapi S.A.
• 31.7. United Therapeutics Corporation
• 31.8. Pfizer CentreOne
• 31.9. Sai Life Sciences Limited
• 31.10. Zhejiang Ausun Pharmaceutical Co. Ltd.
• 31.11. Yonsung Fine Chemicals Co. Ltd.
• 31.12. Cayman Pharma S.r.o.
• 31.13. Meitheal Pharmaceuticals Inc.
• 31.14. Smiths Medical
• 31.15. Guangzhou Tosun Pharmaceutical Co. Ltd.

32. Global VELETRI Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The VELETRI Market

34. Recent Developments In The VELETRI Market

35. VELETRI Market High Potential Countries, Segments and Strategies

• 35.1 VELETRI Market In 2029 - Countries Offering Most New Opportunities
• 35.2 VELETRI Market In 2029 - Segments Offering Most New Opportunities
• 35.3 VELETRI Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer